Brooklyn ImmunoTherapeutics (BTX) Competitors $0.61 -0.09 (-12.77%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsTrends BTX vs. ALFIW, and NLOKShould you be buying Brooklyn ImmunoTherapeutics stock or one of its competitors? The main competitors of Brooklyn ImmunoTherapeutics include Alfi (ALFIW), and NortonLifeLock (NLOK). These companies are all part of the "information" sector. Brooklyn ImmunoTherapeutics vs. Alfi NortonLifeLock Brooklyn ImmunoTherapeutics (NYSE:BTX) and Alfi (NASDAQ:ALFIW) are both information companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment, community ranking and analyst recommendations. Does the media refer more to BTX or ALFIW? In the previous week, Brooklyn ImmunoTherapeutics' average media sentiment score of 0.00 equaled Alfi'saverage media sentiment score. Company Overall Sentiment Brooklyn ImmunoTherapeutics Neutral Alfi Neutral Is BTX or ALFIW more profitable? Company Net Margins Return on Equity Return on Assets Brooklyn ImmunoTherapeuticsN/A N/A N/A Alfi N/A N/A N/A Do institutionals and insiders have more ownership in BTX or ALFIW? 26.0% of Brooklyn ImmunoTherapeutics shares are held by institutional investors. 20.5% of Brooklyn ImmunoTherapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has better valuation and earnings, BTX or ALFIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrooklyn ImmunoTherapeuticsN/AN/AN/A-$2.27-0.27Alfi$200.68KN/AN/AN/AN/A Does the MarketBeat Community favor BTX or ALFIW? Brooklyn ImmunoTherapeutics and Alfi both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformBrooklyn ImmunoTherapeuticsOutperform VotesNo VotesUnderperform Votes95100.00% AlfiN/AN/A SummaryBrooklyn ImmunoTherapeutics beats Alfi on 2 of the 3 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Brooklyn ImmunoTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart BTX vs. The Competition Export to ExcelMetricBrooklyn ImmunoTherapeuticsTelevision Broadcasting IndustryInformation SectorNYSE ExchangeMarket Cap$36.16M$36.16M$5.64B$19.85BDividend YieldN/AN/A3.69%3.52%P/E Ratio-0.27N/A8.0342.73Price / SalesN/AN/A5.9719.27Price / CashN/AN/AN/A17.86Price / BookN/AN/AN/A5.52Net IncomeN/AN/AN/A$986.45M7 Day Performance-34.61%-34.61%-5.44%0.45%1 Month Performance-39.74%-39.74%-4.49%1.05%1 Year Performance-43.61%-43.61%0.99%24.67% Brooklyn ImmunoTherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTXBrooklyn ImmunoTherapeuticsN/A$0.61-12.8%N/A-37.6%$36.16MN/A-0.27N/AGap DownALFIWAlfiN/A$0.00flatN/AN/A$0.00$200,684.000.0040NLOKNortonLifeLock0.9831 of 5 stars$29.44+0.7%N/A+41.5%$16.82B$2.82B20.59N/AAnalyst ForecastNews Coverage Related Companies and Tools Related Companies ALFIW Competitors NLOK Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brooklyn ImmunoTherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Brooklyn ImmunoTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
